Cartilage repair: Past and future - Lessons for regenerative medicine: Regenerative Medicine Review Series

Journal of Cellular and Molecular Medicine

Volumn 13, Issue 5, 2009, Pages 792-810

  Van Osch, Gerjo J V M ^a,i   Brittberg, Mats ^b   Dennis, James E ^c   Bastiaansen Jenniskens, Yvonne M ^a   Erben, Reinhold G ^d   Konttinen, Yrjö T ^e,f,g   Luyten, Frank P ^h  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF VETERINARY MEDICINE   (Austria)

^e HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^f ORTON ORTHOPAEDIC HOSPITAL   (Finland)

^g COXA Hospital for Joint Replacement ^*  (Finland)

^h UNIVERSITY OF LEUVEN   (Belgium)

ⁱ NONE   (Netherlands)

Author keywords

Autologous chondrocyte implantation; Cartilage repair; Cell types; Clinical study; Growth factors; Inflammation

Indexed keywords

TISSUE SCAFFOLD;

ADULT STEM CELL; ALLOTRANSPLANTATION; ANIMAL; ARTHROPATHY; ARTICLE; ARTICULAR CARTILAGE; CARTILAGE CELL; CELL DIFFERENTIATION; CELL TRANSPLANTATION; CYTOLOGY; EMBRYONIC STEM CELL; HUMAN; MESENCHYMAL STEM CELL TRANSPLANTATION; ORTHOPEDIC SURGERY; PATHOLOGY; RANDOMIZED CONTROLLED TRIAL; REGENERATION; TISSUE ENGINEERING; TRANSPLANTATION;

ADULT STEM CELLS; ANIMALS; CARTILAGE, ARTICULAR; CELL DIFFERENTIATION; CELL TRANSPLANTATION; CHONDROCYTES; EMBRYONIC STEM CELLS; HUMANS; JOINT DISEASES; MESENCHYMAL STEM CELL TRANSPLANTATION; ORTHOPEDIC PROCEDURES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REGENERATION; TISSUE ENGINEERING; TISSUE SCAFFOLDS; TRANSPLANTATION, HOMOLOGOUS;

EID: 67249154340     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2009.00789.x     Document Type: Article

References (186)

1. Convery FR, Akeson WH, Keown GH. The repair of large osteochondral defects. An experimental study in horses. Clin Orthop Relat Res. 1972 82 : 253 62.
2. Mankin HJ. The response of articular cartilage to mechanical injury. J Bone Joint Surg Am. 1982 64 : 460 6.
3. Shapiro F, Koide S, Glimcher MJ. Cell origin and differentiation in the repair of full-thickness defects of articular cartilage. J Bone Joint Surg Am. 1993 75 : 532 53.
4. Verwoerd-Verhoef HL, ten Koppel PG, van Osch GJ, Meeuwis CA, Verwoerd CD. Wound healing of cartilage structures in the head and neck region. Int J Pediatr Otorhinolaryngol. 1998 43 : 241 51.
5. Bos PK, van Osch GJ, Frenz DA, Verhaar JA, Verwoerd-Verhoef HL. Growth factor expression in cartilage wound healing: temporal and spatial immunolocalization in a rabbit auricular cartilage wound model. Osteoarthritis Cartilage. 2001 9 : 382 9.
6. Brittberg M, Lindahl A, Nilsson A, Ohlsson C, Isaksson O, Peterson L. Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation. N Engl J Med. 1994 331 : 889 95.
7. Brittberg M, Peterson L, Sjogren-Jansson E, Tallheden T, Lindahl A. Articular cartilage engineering with autologous chondrocyte transplantation. A review of recent developments. J Bone Joint Surg Am. 2003 85-A : 109 15.
8. Minas T, Chiu R. Autologous chondrocyte implantation. Am J Knee Surg. 2000 13 : 41 50.
9. Bentley G, Biant LC, Carrington RW, Akmal M, Goldberg A, Williams AM, Skinner JA, Pringle J. A prospective, randomised comparison of autologous chondrocyte implantation versus mosaicplasty for osteochondral defects in the knee. J Bone Joint Surg Br. 2003 85 : 223 30.
10. Gillogly SD. Treatment of large full-thickness chondral defects of the knee with autologous chondrocyte implantation. Arthroscopy. 2003 19 : 147 53.
11. Lohmander LS. Tissue engineering of cartilage: do we need it, can we do it, is it good and can we prove it? Novartis Found Symp. 2003 249 : 2 10.
12. Behrens P, Bitter T, Kurz B, Russlies M. Matrix-associated autologous chondrocyte transplantation-implantation (MACT-MACI) - 5-year follow-up. Knee. 2006 13 : 194 202. (Pubitemid 44096873)
13. Zheng M, Willer C, Krilak L, Yates P, Xu J, Wood D, Shimmen A. Matrix-induced autologous chondrocyte implantation (MACI): biological and histological assessment. Tissue Eng. 2007 13 : 737 46.
14. Marcacci M, Zaffagnini S, Kon E, Visani A, Iacono F, Loreti I. Arthroscopic autologous chondrocyte transplantation: technical note. Knee Surg Sports Traumatol Arthrosc. 2002 10 : 154 9.
15. Marcacci M, Kon E, Zaffagnini S, Filardo G, Delcogliano M, Neri M, Iacono F, Hollander A. Arthroscopic second generation autologous chondrocyte implantation. Knee Surg Sports Traumatol Arthrosc. 2007 15 : 610 9.
16. Horas U, Pelinkovic D, Herr G, Aigner T, Schnettler R. Autologous chondrocyte implantation and osteochondral cylinder transplantation in cartilage repair of the knee joint. A prospective, comparative trial. J Bone Joint Surg Am. 2003 85-A : 185 92.
17. Dozin B, Malpeli M, Cancedda R, Bruzzi P, Calcagno S, Molfetta L, Priano F, Kon E, Marcacci M. Comparative evaluation of autologous chondrocyte implantation and mosaicplasty: a multicentered randomized clinical trial. Clin J Sport Med. 2005 15 : 220 6.
18. Knutsen G, Drogset JO, Engebretsen L, Grontvedt T, Isaksen V, Ludvigsen TC, Roberts S, Solheim E, Strand T, Johansen O. A randomized trial comparing autologous chondrocyte implantation with microfracture. Findings at five years. J Bone Joint Surg Am. 2007 89 : 2105 12.
19. Saris D, Vanlauwe J, Victor J, Haspl M, Bohnsack M, Fortems Y, Vandekerckhove B, Almqvist KF, Claes T, Handelberg F, Lagae K, Van Der Bauwhede J, Vandenneucker H, Yang KG, Jelic M, Verdonk R, Veulemans N, Bellemans J, Luyten FP. Characterized chondrocyte implantation results in better structural repair when treating symptomatic cartilage defects of the knee in a randomized controlled trial versus microfracture. Am J Sports Med. 2008 36 : 235 46.
20. Bartlett W, Skinner JA, Gooding CR, Carrington RW, Flanagan AM, Briggs TW, Bentley G. Autologous chondrocyte implantation versus matrix-induced autologous chondrocyte implantation for osteochondral defects of the knee: a prospective, randomised study. J Bone Joint Surg Br. 2005 87 : 640 5.
21. Gooding CR, Bartlett W, Bentley G, Skinner J, Carrington R, Flanagan A. A Prospective, randomised study comparing two techniques of autologous chondrocyte implantation for osteochondral defects in the knee: periosteum covered versustype I-II collagen covered. Knee. 2006 13 : 203 10.
22. Wasiak J, Clar C, Villanueva E. Autologous cartilage implantation for full thickness articulair cartilage defects of the knee. Cochrane Database Rev. 2006 3 : CD003323.
23. Vavken P, Gruber M, Dorotka R. Tissue engineering in orthopaedic surgery - clinical effectiveness and cost effectiveness of autologous chondrocyte transplantation. Z Orthop Unfall. 2008 146 : 26 30.
24. Dell'Accio F, De Bari C, Luyten FP. Molecular markers predictive of the capacity of expanded human articular chondro-cytes to form stable cartilage in vivo. Arthritis Rheum. 2001 44 : 1608 19.
25. Benya PD, Shaffer JD. Dedifferentiated chondrocytes reexpress the differentiated collagen phenotype when cultured in agarose gels. Cell. 1982 30 : 215 24.
26. von der Mark K, Gauss V, von der Mark H, Muller P. Relationship between cell shape and type of collagen synthesised as chondrocytes lose their cartilage phenotype in culture. Nature. 1977 267 : 531 2.
27. Ikeda T, Kamekura S, Mabuchi A, Kou I, Seki S, Takato T, Nakamura K, Kawaguchi H, Ikegawa S, Chung UI. The combination of SOX5, SOX6, and SOX9 (the SOX trio) provides signals sufficient for induction of permanent cartilage. Arthritis Rheum. 2004 50 : 3561 73.
28. Kafienah W, Jakob M, Demarteau O, Frazer A, Barker MD, Martin I, Hollander AP. Three-dimensional tissue engineering of hyaline cartilage: comparison of adult nasal and articular chondrocytes. Tissue Eng. 2002 8 : 817 26.
29. van Osch GJ, Marijnissen W, Van Der Veen S, Verwoerd-Verhoef H. The potency of culture-expanded nasal septum chondrocytes for tissue engineering of cartilage. Am J Rhinol. 2001 15 : 187 92.
30. van Osch GJ, Van Der Veen S, Verwoerd-Verhoef H. In vitro redifferentiation of culture-expanded rabbit and human auriculair chondrocytes for cartilage reconstruction. Plast Reconstr Surg. 2001 107 : 433 40.
31. Henderson JH, Welter JF, Mansour JM, Niyibizi C, Caplan AI, Dennis JE. Cartilage tissue engineering for laryngotra-cheal reconstruction: comparison of chondrocytes from three anatomic locations in the rabbit. Tissue Eng. 2007 13 : 843 53.
32. Naumann A, Dennis JE, Awadallah A, Carrino DA, Mansour JM, Kastenbauer E, Caplan AI. Immunochemical and mechanical characterization of cartilage subtypes in rabbit. J Histochem Cytochem. 2002 50 : 1049 58.
33. Isogai N, Kusuhara H, Ikada Y, Ohtani H, Jacquet R, Hillyer J, Lowder E, Landis WJ. Comparison of different chondrocytes for use in tissue engineering of cartilage model structures. Tissue Eng. 2006 12 : 691 703. (Pubitemid 43726514)
34. Chung C, Erickson IE, Mauck RL, Burdick JA. Differential behavior of auricular and articular chondrocytes in hyaluronic acid hydrogels. Tissue Eng Part A. 2008 14 : 1121 31.
35. Panossian A, Ashiku S, Kirchhoff CH, Randolph MA, Yaremchuk MJ. Effects of cell concentration and growth period on articular and ear chondrocyte transplants for tissue engineering. Plast Reconstr Surg. 2001 108 : 392 402. (Pubitemid 32706071)
36. Tay AG, Farhadi J, Suetterlin R, Pierer G, Heberer M, Martin I. Cell yield, proliferation, and postexpansion differentiation capacity of human ear, nasal, and rib chondrocytes. Tissue Eng. 2004 10 : 762 70.
37. Yokoyama A, Muneta T, Nimura A, Koga H, Mochizuki T, Hata Y, Sekiya I. FGF2 and dexamethasone increase the production of hyaluronan in two-dimensional culture of elastic cartilage-derived cells: in vitro analyses and in vivo cartilage formation. Cell Tissue Res. 2007 329 : 469 78.
38. Van Osch GJ, Mandl EW, Jahr H, Koevoet W, Nolst-Trenite G, Verhaar JA. Considerations on the use of ear chondro-cytes as donor chondrocytes for cartilage tissue engineering. Biorheology. 2004 41 : 411 21.
39. Klein TJ, Schumacher BL, Schmidt TA, Li KW, Voegtline MS, Masuda K, Thonar EJ, Sah RL. Tissue engineering of stratified articular cartilage from chondrocyte sub-populations. Osteoarthritis Cartilage. 2003 11 : 595 602. (Pubitemid 36926535)
40. Kim TK, Sharma B, Williams CG, Ruffner MA, Malik A, McFarland EG, Elisseeff JH. Experimental model for cartilage tissue engineering to regenerate the zonal organization of articular cartilage. Osteoarthritis Cartilage. 2003 11 : 653 64.
41. Skoog T, Ohlsen L, Sohn SA. Perichondrial potential for cartilagenous regeneration. Scand J Plast Reconstr Surg. 1972 6 : 123 5.
42. Homminga G, Bulstra S, Bouwmeester P, Van Der Linden A. Perichondral grafting for cartilage lesions of the knee. J Bone Joint Surg Br. 1990 72 : 1003 7.
43. Bouwmeester P, Kuijer R, Homminga G, Bulstra S, Geesink R. A retrospective analysis of two independent prospective cartilage repair studies: antogenous perichondral grafting versus subchondral drilling 10 years post-surgery. J Orthop Res. 2002 20 : 267 73.
44. Van Osch GJ, Van Der Veen SW, Burger EH, Verwoerd-Verhoef HL. Chondrogenic potential of in vitro multiplied rabbit perichondrium cells cultured in alginate beads in defined medium. Tissue Eng. 2000 6 : 321 30.
45. Togo T, Utani A, Naitoh M, Ohta M, Tsuji Y, Morikawa N, Nakamura M, Suzuki S. Identification of cartilage progenitor cells in the adult ear perichondrium: utilization for cartilage reconstruction. Lab Invest. 2006 86 : 445 57.
46. Yoo JU, Barthel TS, Nishimura K, Solchaga L, Caplan AI, Goldberg VM, Johnstone B. The chondrogenic potential of human bone-marrow-derived mesenchymal progenitor cells. J Bone Joint Surg Am. 1998 80 : 1745 57.
47. Wakitani S, Goto T, Pineda SJ, Young RG, Mansour JM, Caplan AI, Goldberg VM. Mesenchymal cell-based repair of large, full-thickness defects of articular cartilage. J Bone Joint Surg Am. 1994 76 : 579 92.
48. Solchaga LA, Yoo JU, Lundberg M, Dennis JE, Huibregtse BA, Goldberg VM, Caplan AI. Hyaluronan-based polymers in the treatment of osteochondral defects. J Orthop Res. 2000 18 : 773 80.
49. Solchaga LA, Gao J, Dennis JE, Awadallah A, Lundberg M, Caplan AI, Goldberg VM. Treatment of osteochondral defects with autologous bone marrow in a hyaluronan-based delivery vehicle. Tissue Eng. 2002 8 : 333 47.
50. Zhou XZ, Leung VY, Dong QR, Cheung KM, Chan D, Lu WW. Mesenchymal stem cell-based repair of articular cartilage with polyglycolic acid-hydroxyapatite biphasic scaffold. Int J Artif Organs. 2008 31 : 480 9.
51. Guo X, Zheng Q, Yang S, Shao Z, Yuan Q, Pan Z, Tang S, Liu K, Quan D. Repair of full-thickness articular cartilage defects by cultured mesenchymal stem cells transfected with the transforming growth factor beta1 gene. Biomed Mater. 2006 1 : 206 15.
52. Park MS, Kim SS, Cho SW, Choi CY, Kim BS. Enhancement of the osteogenic efficacy of osteoblast transplantation by the sustained delivery of basic fibroblast growth factor. J Biomed Mater Res. 2006 79 : 353 9.
53. Wakitani S, Imoto K, Yamamoto T, Saito M, Murata N, M. Y. Human autologous culture expanded bone marrow mesenchymal cell transplantation for repair of cartilage defects in osteoarthritic knees. Osteoarthritis Cartilage. 2002 10 : 199 206. (Pubitemid 34189569)
54. Wakitani S, Mitsuoka T, Nakamura N, Toritsuka Y, Nakamura Y, Horibe S. Autologous bone marrow stromal cell transplantation for repair of full-thickness articular cartilage defects in human patellae: two case reports. Cell Transplant 2004 13 : 595 600. (Pubitemid 39557438)
55. Centeno CJ, Busse D, Kisiday J, Keohan C, Freeman M, Karli D. Increased knee cartilage volume in degenerative joint disease using percutaneously implanted autologous mesenchymal stem cells. Pain Physician. 2008 11 : 343 53.
56. Dennis JE, Carbillet JP, Caplan Al, Charbord P. The STRO-1 + marrow cell population is multipotential. Cells Tissues Organs. 2002 170 : 73 82.
57. Farrell E, Van Der Jagt OP, Koevoet W, Kops N, van Manen CJ, Hellingman CA, Jahr H, O'Brien FJ, Verhaar JA, Weinans H, van Osch GJ. Chondrogenic priming of human bone marrow stromal cells: a better route to bone repair? Tissue Eng Part A. doi :.
58. Pelttari K, Winter A, Steck E, Goetzke K, Hennig T, Ochs BG, Aigner T, Richter W. Premature induction of hypertrophy during in vitro chondrogenesis of human mesenchymal stem cells correlates with calcification and vascular invasion after ectopic transplantation in SCID mice. Arthritis Rheum. 2006 54 : 3254 66.
59. Liu K, Zhou GD, Liu W, Zhang WJ, Cui L, Liu X, Liu TY, Cao Y. The dependence of in vivo stable ectopic chondrogenesis by human mesenchymal stem cells on chondrogenic differentiation in vitro. Biomaterials. 2008 29 : 2183 92.
60. Caplan AL Dennis JE. Mesenchymal stem cells as trophic mediators. J Cell Biochem. 2006 98 : 1076 84.
61. Hoogduijn MJ, Crop MJ, Peeters AM, Van Osch GJ, Balk AH, Ijzermans JN, Weimar W, Baan CC. Human heart spleen, and perirenal fat-derived mesenchymal stem cells have immunomodulatory capacities. Stem Cells Dev. 2007 16 : 597 604. (Pubitemid 47378732)
62. Chen L, Tredget E, Wu P, Wu Y. Paracrine factors of mesenchymal stem cells recruit macrophages and endolithial lineage cells and enhance wound healing. PLoS ONE. 2008 3 : e1886.
63. Zuk PA, Zhu M, Mizuno H, Huang J, Futrell JW, Katz AJ, Benhaim P, Lorenz HP, Hedrick MH. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng. 2001 7 : 211 28.
64. Rich JT, Rosova I, Nolta JA, Myckatyn TM, Sandell LJ, McAlinden A. Upregulation of Runx2 and Osterix during in vitrochondrogenesis of human adipose-derived stromal cells. Biochem Biophys Res Commun. 2008 372 : 230 5.
65. Hennig T, Lorenz H, Thiel A, Goetzke K, Dickhut A, Geiger F, Richter W. Reduced chondrogenic potential of adipose tissue derived stromal cells correlates with an altered TGFbeta receptor and BMP profile and is overcome by BMP-6. J Cell Physiol. 2007 211 : 682 91.
66. De Bari C, Dell'Accio F, Luyten FP. Failure of in vitro differentiated mesenchymal stem cells from the synovial membrane to form ectopic stable cartilage in vivo. Arthritis Rheum. 2004 50 : 142 50.
67. Sakaguchi Y, Sekiya I, Yagishita K, Muneta T. Comparison of human stem cells derived from various mesenchymal tissues: superiority of synovium as a cell source. Arthritis Rheum. 2005 52 : 2521 9.
68. Shirasawa S, Sekiya I, Sakaguchi Y, Yagishita K, Ichinose S, Muneta T. In vitro chondrogenesis of human synovium-derived mesenchymal stem cells: optimal condition and comparison with bone marrow-derived cells. J Cell Biochem. 2006 97 : 84 97. (Pubitemid 43050181)
69. Jones EA, English A, Henshaw K, Kinsey SE, Markham AF, Emery P, McGonagle D. Enumeration and phenotypic characterization of synovial fluid multipotential mesenchymal progenitor cells in inflammatory and degenerative arthritis. Arthritis Rheum. 2004 50 : 817 27.
70. Koyama E, Shibukawa Y, Nagayama M, Sugito H, Young B, Yuasa T, Okabe T, Ochiai T, Kamiya N, Rountree RB, Kingsley DM, Iwamoto M, Enomoto-Iwamoto M, Pacifici M. A distinct cohort of progenitor cells participates in synovial joint and articular cartilage formation during mouse limb skeletogenesis. Dev Biol. 2008 316 : 62 73.
71. Kim J, Lee Y, Kim H, Hwang KJ, Kwon HC, Kim SK, Cho DJ, Kang SG, You J. Human amniotic fluid-derived stem cells have characteristics of multipotent stem cells. Cell Prolif. 2007 40 : 75 90. (Pubitemid 46103692)
72. Kogler G, Sensken S, Airey JA, Trapp T, Muschen M, Feldhahn N, Liedtke S, Sorg RV, Fischer J, Rosenbaum C, Greschat S, Knipper A, Bender J, Degistirici O, Gao J, Caplan AI, Colletti EJ, Almeida-Porada G, Muller HW, Zanjani E, Wernet P. A new human somatic stem cell from placental cord blood with intrinsic pluripotent differentiation potential. J Exp Med. 2004 200 : 123 35.
73. Mos L, Cooper GA, Serben K, Cameron M, Koop BF. Effects of diesel on survival, growth, and gene expression in rainbow trout (Oncorhynchus mykiss) fry. Environ Sci Technol. 2008 42 : 2656 62.
74. Vats A, Bielby RC, Tolley N, Dickinson SC, Boccaccini AR, Hollander AP, Bishop AE, Polak JM. Chondrogenic differentiation of human embryonic stem cells: the effect of the micro-environment. Tissue Eng. 2006 12 : 1687 97.
75. Koay EJ, Athanasiou KA. Hypoxic chondrogenic differentiation of human embryonic stem cells enhances cartilage protein synthesis and biomechanical functionality. Osteoarthritis Cartilage. 2008 16 : 1450 6.
76. Jukes JM, Both SK, Leusink A, Sterk LM, van Blitterswijk CA, de Boer J. Endochondral bone tissue engineering using embryonic stem cells. Proc Natl Acad Sci USA. 2008 105 : 6840 5.
77. Hegert C, Kramer J, Hargus G, Muller J, Guan K, Wobus AM, Muller PK, Rohwedel J. Differentiation plasticity of chondrocytes derived from mouse embryonic stem cells. J Cell Sci. 2002 115 : 4617 28.
78. Hwang N, Varghese S, Elisseeff J. Derivation of chondrogenically- committed cells from human embryonic cells for cartilage tisssue regeneration. PLoS ONE. 2008 3 : e2498.
79. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006 126 : 663 76.
80. Meissner A, Wernig M, Jaenisch R. Direct reprogramming of genetically unmodified fibroblasts into pluripotent stem cells. Nature Biotechnol. 2007 25 : 1177 81.
81. Maherali N, Sridharan R, Xie W, Utikal J, Eminli S, Arnold K, Stadtfeld M, Yachechko R, Tchieu J, Jaenisch R, Plath K, Hochedlinger K. Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution. Cell Stem Cell. 2007 1 : 55 70.
82. Okita K, Ichisaka T, Yamanaka S. Generation of germline-competent induced pluripotent stem cells. Nature. 2007 448 : 313 7.
83. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, Yamanaka S. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 2007 131 : 861 72.
84. Yaeger PC, Masi TL, de Ortiz JL, Binette F, Tubo R, McPherson JM. Synergistic action of transforming growth factor-beta and insulin-like growth factor-I induces expression of type II collagen and aggrecan genes in adult human articular chondrocytes. Exp Cell Res. 1997 237 : 318 25.
85. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR. Multilineage potential of adult human mesenchymal stem cells. Science. 1999 284 : 143 7.
86. Johnstone B, Hering TM, Caplan AI, Goldberg VM, Yoo JU. In vitro chondrogenesis of bone marrow-derived mesenchy-mal progenitor cells. Exp Cell Res. 1998 238 : 265 72.
87. Mackay AM, Beck SC, Murphy JM, Barry FP, Chichester CO, Pittenger MF. Chondrogenic differentiation of cultured human mesenchymal stem cells from marrow. Tissue Eng. 1998 4 : 415 28.
88. Mehlhorn AT, Niemeyer P, Kaschte K, Muller L, Finkenzeller G, Hartl D, Sudkamp NP, Schmal H. Differential effects of BMP-2 and TGF-beta1 on chondrogenic differentiation of adipose derived stem cells. Cell Prolif. 2007 40 : 809 23.
89. Hanada K, Solchaga LA, Caplan AI, Hering TM, Goldberg VM, Yoo JU, Johnstone B. BMP-2 induction and TGF-beta 1 modulation of rat periosteal cell chondrogenesis. J Cell Biochem. 2001 81 : 284 94.
90. Luyten FP, Yu YM, Yanagishita M, Vukicevic S, Hammonds RG, Reddi AH. Natural bovine osteogenin and recombi-nant human bone morphogenetic protein-2B are equipotent in the maintenance of proteoglycans in bovine articular cartilage explant cultures. J Biol Chem. 1992 267 : 3691 5.
91. Ito T, Sawada R, Fujiwara Y, Tsuchiya T. FGF-2 increases osteogenic and chondrogenic differentiation potentials of human mesenchymal stem cells by inactivation of TGF-beta signaling. Cytotechnology. 2008 56 : 1 7.
92. Xu D, Gechtman Z, Hughes A, Collins A, Dodds R, Cui X, Jolliffe L, Higgins L, Murphy A, Farrell F. Potential involvement of BMP receptor type IB activation in a synergistic effect of chondrogenic promotion between rhTGFbeta3 and rhGDF5 or rhBMP7 in human mesenchymal stem cells. Growth Factors. 2006 24 : 268 78.
93. Longobardi L, O'Rear L, Aakula S, Johnstone B, Shimer K, Chytil A, Horton WA, Moses HL, Spagnoli A. Effect of IGF-I in the chondrogenesis of bone marrow mesenchymal stem cells in the presence or absence of TGF-beta signaling. J Bone Miner Res. 2006 21 : 626 36.
94. Chen WH, Lo WC, Lee JJ, Su CH, Lin CT, Liu HY, Lin TW, Lin WC, Huang TY, Deng WP. Tissue-engineered intervertebral disc and chondrogenesis using human nucleus pulposus regulated through TGF-beta1 in platelet-rich plasma. J Cell Physiol. 2006 209 : 744 54.
95. Fortier LA, Mohammed HO, Lust G, Nixon AJ. Insulin-like growth factor-I enhances cell-based repair of articular cartilage. J Bone Joint Surg Br. 2002 84 : 276 88.
96. Sellers RS, Zhang R, Glasson SS, Kim HD, Peluso D, D'Augusta DA, Beckwith K, Morris EA. Repair of articular cartilage defects one year after treatment with recombinant human bone morphogenetic protein-2 (rhBMP-2). J Bone Joint Surg Am. 2000 82 : 151 60.
97. Louwerse RT, Heyligers IC, Klein-Nulend J, Sugihara S, van Kampen GP, Semeins CM, Goei SW, de Koning MH, Wuisman PI, Burger EH. Use of recombinant human osteogenic protein-1 for the repair of sub-chondral defects in articular cartilage in goats. J Biomed Mater Res. 2000 49 : 506 16.
98. Harrison ET Jr., Luyten F P, Reddi AH. Transforming growth factor-beta: its effect on phenotype reexpression by dedifferentiated chondrocytes in the presence and absence of osteogenin. In Vitro Cell Dev Biol. 1992 28A : 445 8.
99. Barbero A, Ploegert S, Heberer M, Martin I. Plasticity of clonal populations of dedifferentiated adult human articular chondrocytes. Arthritis Rheum. 2003 48 : 1315 25.
100. Jakob M, Demarteau O, Schafer D, Hintermann B, Dick W, Heberer M, Martin I. Specific growth factors during the expansion and redifferentiation of adult human articular chondrocytes enhance chondrogenesis and cartilaginous tissue formation in vitro. J Cell Biochem. 2001 81 : 368 77.
101. Mandl EW, Jahr H, Koevoet JL, van Leeuwen JP, Weinans H, Verhaar JA, van Osch GJ. Fibroblast growth factor-2 in serum-free medium is a potent mitogen and reduces dedifferentiation of human ear chondrocytes in monolayer culture. Matrix Biol. 2004 23 : 231 41.
102. Solchaga LA, Penick K, Porter JD, Goldberg VM, Caplan AI, Welter JF. FGF-2 enhances the mitotic and chondrogenic potentials of human adult bone marrow-derived mesenchymal stem cells. J Cell Physiol. 2005 203 : 398 409. (Pubitemid 40471774)
103. Luyten FP, Hascall VC, Nissley SP, Morales TI, Reddi AH. Insulin-like growth factors maintain steady-state metabolism of proteoglycans in bovine articular cartilage explants. Arch Biochem Biophys. 1988 267 : 416 25.
104. Jenniskens YM, Koevoet W, de Bart AC, Weinans H, Jahr H, Verhaar JA, DeGroot J, van Osch GJ. Biochemical and functional modulation of the cartilage collagen network by IGF1, TGFbeta2 and FGF2. Osteoarthritis Cartilage. 2006 14 : 1136 46.
105. Hui W, Rowan AD, Cawston T. Modulation of the expression of matrix metalloproteinase and tissue inhibitors of metalloproteinases by TGF-beta1 and IGF-1 in primary human articular and bovine nasal chondrocytes stimulated with TNF-alpha. Cytokine. 2001 16 : 31 5.
106. Hui W, Rowan AD, Cawston T. Insulin-like growth factor 1 blocks collagen release and down regulates matrix metalloproteinase-1, -3, -8, and -13 mRNA expression in bovine nasal cartilage stimulated with oncostatin M in combination with interleukin 1alpha. Ann Rheum Dis. 2001 60 : 254 61.
107. Chubinskaya S, Hurtig M, Rueger DC. OP-1-BMP-7 in cartilage repair. Int Orthop. 2007 31 : 773 81.
108. Nixon AJ, Haupt JL, Frisbie DD, Morisset SS, McIlwraith CW, Robbins PD, Evans CH, Ghivizzani S. Genemediated restoration of cartilage matrix by combination insulin-like growth factor-I-interleukin-1 receptor antagonist therapy. Gene Ther. 2005 12 : 177 86.
109. Im HJ, Muddasani P, Natarajan V, Schmid TM, Block JA, Davis F, van Wijnen AJ, Loeser RF. Basic fibroblast growth factor stimulates matrix metallo-proteinase-13 viathe molecular cross-talk between the mitogen-activated protein kinases and protein kinase Cdelta pathways in human adult articular chondrocytes. J Biol Chem. 2007 282 : 11110 21.
110. Kaul G, Cucchiarini M, Arntzen D, Zurakowski D, Menger MD, Kohn D, Trippel SB, Madry H. Local stimulation of articular cartilage repair by transplantation of encapsulated chondrocytes overex-pressing human fibroblast growth factor 2 (FGF-2) in vivo. J Gene Med. 2006 8 : 100 11.
111. Ishii I, Mizuta H, Sei A, Hirose J, Kudo S, Hiraki Y. Healing of full-thickness defects of the articular cartilage in rabbits using fibroblast growth factor-2 and a fibrin sealant. J Bone Joint Surg Br. 2007 89 : 693 700. (Pubitemid 46958782)
112. Mandl EW, Van Der Veen SW, Verhaar JA, van Osch GJ. Serum-free medium supplemented with high-concentration FGF2 for cell expansion culture of human ear chondrocytes promotes redifferentiation capacity. Tissue Eng. 2002 8 : 573 80.
113. Mandl EW, Van Der Veen SW, Verhaar JA, van Osch GJ. Multiplication of human chondrocytes with low seeding densities accelerates cell yield without losing redifferentiation capacity. Tissue Eng. 2004 10 : 109 18.
114. Sawaji Y, Hynes J, Vincent T, Saklatvala J. Fibroblast growth factor 2 inhibits induction of aggrecanase activity in human articular cartilage. Arthritis Rheum. 2008 58 : 3498 509.
115. Moore EE, Bendele AM, Thompson DL, Littau A, Waggie KS, Reardon B, Ellsworth JL. Fibroblast growth factor-18 stimulates chondrogenesis and cartilage repair in a rat model of injury-induced osteoarthritis. Osteoarthritis Cartilage. 2005 13 : 623 31.
116. Ellsworth JL, Berry J, Bukowski T, Claus J, Feldhaus A, Holderman S, Holdren MS, Lum KD, Moore EE, Raymond F, Ren H, Shea P, Sprecher C, Storey H, Thompson DL, Waggie K, Yao L, Fernandes RJ, Eyre DR, Hughes SD. Fibroblast growth factor-18 is a trophic factor for mature chondrocytes and their progenitors. Osteoarthritis Cartilage. 2002 10 : 308 20.
117. Bastiaansen-Jenniskens YM, Koevoet W, De Bart AC, De Bart AC, Zuurmond AM, Bank RA, Verhaar JA, Degroot J, Van Osch GJ. TGFbeta affects collagen cross-linking independent of chondrocyte phenotype but strongly depending on physical environment. Tissue Eng Part A. 2008 14 : 1059 66.
118. Redini F, Mauviel A, Pronost S, Loyau G, Pujol JP. Transforming growth factor beta exerts opposite effects from interleukin-1 beta on cultured rabbit articular chondrocytes through reduction of interleukin-1 receptor expression. Arthritis Rheum. 1993 36 : 44 50. (Pubitemid 23048677)
119. Grimaud E, Heymann D, Redini F. Recent advances in TGF-beta effects on chondrocyte metabolism. Potential therapeutic roles of TGF-beta in cartilage disorders. Cytokine Growth Factor Rev. 2002 13 : 241 57.
120. Grunder T, Gaissmaier C, Fritz J, Stoop R, Hortschansky P, Mollenhauer J, Aicher WK. Bone morphogenetic protein (BMP)-2 enhances the expression of type II collagen and aggrecan in chondrocytes embedded in alginate beads. Osteoarthritis Cartilage. 2004 12 : 559 67.
121. Stove J, Schneider-Wald B, Scharf HP, Schwarz ML. Bone morphogenetic protein 7 (bmp-7) stimulates proteoglycan synthesis in human osteoarthritic chondrocytes in vitro. Biomed Pharmacother. 2006 60 : 639 43.
122. Hicks DL, Sage AB, Shelton E, Schumacher BL, Sah RL, Watson D. Effect of bone morphogenetic proteins 2 and 7 on septal chondrocytes in alginate. Otolaryngol Head Neck Surg. 2007 136 : 373 9.
123. Chubinskaya S, Segalite D, Pikovsky D, Hakimiyan AA, Rueger DC. Effects induced by BMPS in cultures of human articular chondrocytes: comparative studies. Growth Factors. 2008 26 : 275 83.
124. Mailhot G, Yang M, Mason-Savas A, Mackay CA, Leav I, Odgren PR. BMP-5 expression increases during chondrocyte differentiation in vivo and in vitro and promotes proliferation and cartilage matrix synthesis in primary chondrocyte cultures. J Cell Physiol. 2008 214 : 56 64. (Pubitemid 350220059)
125. Blaney Davidson E, Vitters E, van Lent P, van de Loo F, Van Den Berg W, Van Der Kraan P. Elevated extracellulairmatrix production and degradation upon bone morphogenetic protein -2 (BMP-2) stimulation point toward a role for (BMP-2) in cartilagerepair and remodeling. Arthritis Res Ther. 2007 9 : R102.
126. Akeda K, An HS, Okuma M, Attawia M, Miyamoto K, Thonar EJ, Lenz ME, Sah RL, Masuda K. Platelet-rich plasma stimulates porcine articular chondrocyte proliferation and matrix biosynthesis. Osteoarthritis Cartilage. 2006 14 : 1272 80.
127. Marijnissen WJ, van Osch GJ, Aigner J, Verwoerd-Verhoef HL, Verhaar JA. Tissue-engineered cartilage using serially passaged articular chondrocytes. Chondrocytes in alginate, combined in vivo with a synthetic (E210) or biologic biodegradable carrier (DBM). Biomaterials. 2000 21 : 571 80.
128. Marijnissen WJ, van Osch GJ, Aigner J, Van Der Veen SW, Hollander AP, Verwoerd-Verhoef HL, Verhaar JA. Alginate as a chondrocyte-delivery substance in combination with a non-woven scaffold for cartilage tissue engineering. Biomaterials. 2002 23 : 1511 7.
129. Miot S, Woodfield T, Daniels AU, Suetterlin R, Peterschmitt I, Heberer M, van Blitterswijk CA, Riesle J, Martin I. Effects of scaffold composition and architecture on human nasal chondrocyte redifferentiation and cartilaginous matrix deposition. Biomaterials. 2005 26 : 2479 89.
130. Bosnakovski D, Mizuno M, Kim G, Takagi S, Okumura M, Fujinaga T. Chondrogenic differentiation of bovine bone marrow mesenchymal stem cells (MSCs) in different hydrogels: influence of collagen type II extracellular matrix on MSC chondrogenesis. Biotechnol Bioeng. 2006 93 : 1152 63.
131. Oliveira JT, Crawford A, Mundy JM, Moreira AR, Gomes ME, Hatton PV, Reis RL. A cartilage tissue engineering approach combining starch-polycaprolactone fibre mesh scaffolds with bovine articular chondrocytes. J Mater Sci Mater Med. 2007 18 : 295 302. (Pubitemid 46332851)
132. Hunziker EB, Kapfinger E, Geiss J. The structural architecture of adult mammalian articular cartilage evolves by a synchronized process of tissue resorption and neoformation during postnatal development. Osteoarthritis Cartilage. 2007 15 : 403 13.
133. Sohier J, Hamann D, Koenders M, Cucchiarini M, Madry H, van Blitterswijk C, de Groot K, Bezemer JM. Tailored release of TGF-beta1 from porous scaffolds for cartilage tissue engineering. Int J Pharm. 2007 332 : 80 9.
134. Gavenis K, Klee D, Pereira-Paz RM, von Walter M, Mollenhauer J, Schneider U, Schmidt-Rohlfing B. BMP-7 loaded microspheres as a new delivery system for the cultivation of human chondrocytes in a collagen type-I gel. J Biomed Mat Res. 2007 82 : 275 83.
135. Sohier J, Vlugt TJ, Cabrol N, Van Blitterswijk C, de Groot K, Bezemer JM. Dual release of proteins from porous polymeric scaffolds. J Control Release. 2006 111 : 95 106. (Pubitemid 43292485)
136. Ginty PJ, Barry JJ, White LJ, Howdle SM, Shakesheff KM. Controlling protein release from scaffolds using polymer blends and composites. Eur J Pharm Biopharm. 2008 68 : 82 9.
137. Gnecchi M, He H, Noiseux N, Liang OD, Zhang L, Morello F, Mu H, Melo LG, Pratt RE, Ingwall JS, Dzau VJ. Evidence supporting paracrine hypothesis for Akt-modified mesenchymal stem cell-mediated cardiac protection and functional improvement. FASEB J. 2006 20 : 661 9.
138. Saris DB, Dhert WJ, Verbout AJ. Joint homeostasis. The discrepancy between old and fresh defects in cartilage repair. J Bone Joint Surg Br. 2003 85 : 1067 76.
139. Verzijl N, DeGroot J, Bank RA, Bayliss MT, Bijlsma JW, Lafeber FP, Maroudas A, TeKoppele JM. Age-related accumulation of the advanced glycation endproduct pentosidine in human articular cartilage aggrecan: the use of pentosidine levels as a quantitative measure of protein turnover. Matrix Biol. 2001 20 : 409 17.
140. Kume S, Kato S, Yamagishi S, Inagaki Y, Ueda S, Arima N, Okawa T, Kojiro M, Nagata K. Advanced glycation end-products attenuate human mesenchymal stem cells and prevent cognate differentiation into adipose tissue, cartilage, and bone. J Bone Miner Res. 2005 20 : 1647 58.
141. Kreuz PC, Erggelet C, Steinwachs MR, Krause SJ, Lahm A, Niemeyer P, Ghanem N, Uhl M, Sudkamp N. Is microfracture of chondral defects in the knee associated with different results in patients aged 40 years or younger? Arthroscopy. 2006 22 : 1180 6.
142. Rosenberger RE, Gomoll AH, Bryant T, Minas T. Repair of large chondral defects of the knee with autologous chondrocyte implantation in patients 45 years or older. Am J Sports Med. 2008 36 : 2336 44.
143. Vasara AI, Konttinen YT, Peterson L, Lindahl A, Kiviranta I. Persisting high levels of synovial fluid markers after cartilage repair: a pilot study. Clin Orthop Relat Res. 2009 467 : 267 72.
144. Rotter N, Ung F, Roy AK, Vacanti M, Eavey RD, Vacanti CA, Bonassar LJ. Role for interleukin 1alpha in the inhibition of chondrogenesis in autologous implants using polyglycolic acid-polylactic acid scaffolds. Tissue Eng. 2005 11 : 192 200. (Pubitemid 40515187)
145. Haupt JL, Frisbie DD, McIlwraith CW, Robbins PD, Ghivizzani S, Evans CH, Nixon AJ. Dual transduction of insulin-like growth factor-I and interleukin-1 receptor antagonist protein controls cartilage degradation in an osteoarthritic culture model. J Orthop Res. 2005 23 : 118 26.
146. Robertson CM, Allen RT, Pennock AT, Bugbee WD, Amiel D. Upregulation of apoptotic and matrix-related gene expression during fresh osteochondral allograft storage. Clin Orthop Relat Res. 2006 442 : 260 6.
147. Lee JH, Prakash KV, Pengatteeri YH, Park SE, Koh HS, Han CW. Chondrocyte apoptosis in the regenerated articular cartilage after allogenic chondrocyte transplantation in the rabbit knee. J Bone Joint Surg Br. 2007 89 : 977 83.
148. Surendran S, Kim SH, Jee BK, Ahn SH, Gopinathan P, Han CW. Anti-apoptotic Bcl-2 gene transfection of human articular chondrocytes protects against nitric oxide-induced apoptosis. J Bone Joint Surg Br. 2006 88 : 1660 5.
149. Nakachi N, Asoh S, Watanabe N, Mori T, Matsushita T, Takai S, Ohta S. Transduction of anti-cell death protein FNK suppresses graft degeneration after autologous cylindrical osteochondral transplantation. J Histochem Cytochem. 2009 57 : 197 206.
150. Cao L, Lee V, Adams ME, Kiani C, Zhang Y, Hu W, Yang BB. Beta-integrin-collagen interaction reduces chondrocyte apoptosis. Matrix Biol. 1999 18 : 343 55.
151. Lee HJ, Choi BH, Min BH, Park SR. Low-intensity ultrasound inhibits apoptosis and enhances viability of human mesenchymal stem cells in three-dimensional alginate culture during chondrogenic differentiation. Tissue Eng. 2007 13 : 1049 57.
152. Lires-Dean M, Carames B, Cillero-Pastor B, Galdo F, Lopez-Armada MJ, Blanco FJ. Anti-apoptotic effect of transforming growth factor-beta1 on human articular chondrocytes: role of protein phosphatase 2A. Osteoarthritis Cartilage. 2008 16 : 1370 8.
153. Farrell E, Wielopolski P, Pavljasevic P, van Tiel S, Jahr H, Verhaar J, Weinans H, Krestin G, O'Brien FJ, van Osch GJ, Bernsen M. Effects of iron oxide incorporation for long term cell tracking on MSC differentiation in vitro and in vivo. Biochem Biophys Res Commun. 2008 369 : 1076 81.
154. Farrell E, Wielopolski P, Pavljasevic P, Kops N, Weinans H, Bernsen MR, van Osch GJ. Cell labelling with superpara-magnetic iron oxide has no effect on chondrocyte behaviour. Osteoarthritis Cartilage. doi :.
155. Jing XH, Yang L, Duan XJ, Xie B, Chen W, Li Z, Tan HB. In vivo MR imaging tracking of magnetic iron oxide nanoparticle labeled, engineered, autologous bone marrow mesenchymal stem cells following intra-articular injection. Joint Bone Spine. 2008 75 : 432 8.
156. Brazelton TR, Blau HM. Optimizing techniques for tracking transplanted stem cells in vivo. Stem Cells. 2005 23 : 1251 65.
157. Dell'Accio F, Vanlauwe J, Bellemans J, Neys J, De Bari C, Luyten FP. Expanded phenotypically stable chondrocytes persist in the repair tissue and contribute to cartilage matrix formation and structural integration in a goat model of autologous chondrocyte implantation. J Orthop Res. 2003 21 : 123 31.
158. Adachi N, Sato K, Usas A, Fu FH, Ochi M, Han CW, Niyibizi C, Huard J. Muscle derived, cell based ex vivo gene therapy for treatment of full thickness articular cartilage defects. J Rheumatol. 2002 29 : 1920 30.
159. Hirschmann F, Verhoeyen E, Wirth D, Bauwens S, Hauser H, Rudert M. Vital marking of articular chondrocytes by retroviral infection using green fluorescence protein. Osteoarthritis Cartilage. 2002 10 : 109 18.
160. Murphy JM, Fink DJ, Hunziker EB, Barry FP. Stem cell therapy in a caprine model of osteoarthritis. Arthritis Rheum. 2003 48 : 3464 74.
161. Gossler A. Gene and enhancer trap screens in ES cell chimeras. In : Joyner CJ, editor. Gene targeting: a practical approach. New York, NY : Oxford University Press 1993 : pp. 187 227.
162. Cubitt AB, Heim R, Adams SR, Boyd AE, Gross LA, Tsien RY. Understanding, improving and using green fluorescent proteins. Trends Biochem Sci. 1995 20 : 448 55.
163. Zagzag D, Miller DC, Chiriboga L, Yee H, Newcomb EW. Green fluorescent protein immunohistochemistry as a novel experimental tool for the detection of glioma cell invasion in vivo. Brain Pathol. 2003 13 : 34 7.
164. Unger NJ, Odorfer KI, Weber K, Sandgren EP, Erben RG. Utility of human placental alkaline phosphatase as a genetic marker for cell tracking in bone and cartilage. Histochem Cell Biol. 2007 127 : 669 74.
165. Erben RG. Embedding of bone samples in methylmethacrylate: an improved method suitable for bone histomorphom-etry, histochemistry, and immunohisto-chemistry. J Histochem Cytochem. 1997 45 : 307 13.
166. Sarukhan A, Soudais C, Danos O, Jooss K. Factors influencing cross-presentation of non-self antigens expressed from recombinant adeno-associated virus vectors. J Gene Med. 2001 3 : 260 70.
167. Gross DA, Leboeuf M, Gjata B, Danos O, Davoust J. CD4+CD25+ regulatory T cells inhibit immune-mediated transgene rejection. Blood. 2003 102 : 4326 8.
168. Andersson G, Illigens BM, Johnson KW, Calderhead D, LeGuern C, Benichou G, White-Scharf ME, Down JD. Nonmyeloablative conditioning is sufficient to allow engraftment of EGFP-expressing bone marrow and subsequent acceptance of EGFP-transgenic skin grafts in mice. Blood. 2003 101 : 4305 12.
169. Heim DA, Hanazono Y, Giri N, Wu T, Childs R, Sellers SE, Muul L, Agrlcola BA, Metzger ME, Donahue RE, Tlsdale JF, Dunbar CE. Introduction of a xenogeneic gene via hematopoietic stem cells leads to specific tolerance in a rhesus monkey model. Mol Ther. 2000 1 : 533 44.
170. Rosenzweig M, Connole M, Glickman R, Yue SP, Noren B, DeMaria M, Johnson RP. Induction of cytotoxic T lymphocyte and antibody responses to enhanced green fluorescent protein following transplantation of transduced CD34(+) hematopoietic cells. Blood. 2001 97 : 1951 9.
171. Kaab G, Brandl G, Marx A, Wekerle H, Bradl M. The myelin basic protein-specific T cell repertoire in (transgenic) Lewis rat-SCID mouse chimeras: preferential V beta 8.2 T cell receptor usage depends on an intact Lewis thymic microenvironment. Eur J Immunol. 1996 26 : 981 8.
172. Obhrai JS, Oberbarnscheidt M, Zhang N, Mueller DL, Shlomchik WD, Lakkis FG, Shlomchik MJ, Kaplan DH. Langerhans cells are not required for efficient skin graft rejection. J Invest Dermatol. 2008 128 : 1950 5.
173. Mueller M, Wacker K, Hickey WF, Ringelstein EB, Kiefer R. Co-localization of multiple antigens and specific DNA. A novel method using methyl methacrylate-embedded semithin serial sections and catalyzed reporter deposition. Am J Pathol 2000 157 : 1829 38.
174. Odorfer Kl, Unger NJ, Weber K, Sandgren EP, Erben RG. Marker tolerant, immuno-competent animals as a new tool for regenerative medicine and long-term cell tracking. BMC Biotechnol. 2007 7 : 30.
175. Lu Y, Dhanaraj S, Wang Z, Bradley DM, Bowman SM, Cole BJ, Binette F. Minced cartilage without cell culture serves as an effective intraoperative cell source for cartilage repair. J Orthop Res. 2006 24 : 1261 70.
176. Dorotka R, Windberger U, Macfelda K, Bindreiter U, Toma C, Nehrer S. Repair of articular cartilage defects treated by microfracture and a three-dimensional collagen matrix. Biomaterials. 2005 26 : 3617 29.
177. Breinan HA, Martin SD, Hsu HP, Spector M. Healing of canine articular cartilage defects treated with microfracture, a type-II collagen matrix, or cultured autologous chondrocytes. J Orthop Res. 2000 18 : 781 9.
178. Chevrier A, Hoemann CD, Sun J, Buschmann MD. Chitosan-glycerol phosphate-blood implants increase cell recruitment, transient vascularization and subchondral bone remodeling in drilled cartilage defects. Osteoarthritis Cartilage. 2007 15 : 316 27.
179. Zhang X, Zheng Z, Liu P, Ma Y, Lin L, Lang N, Fu X, Zhang J, Ma K, Chen P, Zhou C, Ao Y. The synergistic effects of microfracture, perforated decalcified cortical bone matrix and adenovirus-bone morphogenetic protein-4 in cartilage defect repair. Biomaterials. 2008 29 : 4616 29.
180. Grande DA, Pitman MI, Peterson L, Menche D, Klein M. The repair of experimentally produced defects in rabbit articular cartilage by autologous chondrocyte transplantation. J Orthop Res. 1989 7 : 208 18.
181. Felson DT, Naimark A, Anderson J, Kazis L, Castelli W, Meenan RF. The prevalence of knee osteoarthritis in the elderly. The Framingham Osteoarthritis Study. Arthritis Rheum. 1987 30 : 914 8.
182. Gray ML. Toward imaging biomarkers for glycosaminoglycans. J Bone Joint Surg Am. 2009 91 : 44 9.
183. Eckstein F, Mosher T, Hunter D. Imaging of knee osteoarthritis: data beyond the beauty. Curr Opin Rheumatol. 2007 19 : 435 43.
184. Bauer DC, Hunter DJ, Abramson SB, Attur M, Corr M, Felson D, Heinegård D, Jordan JM, Kepler TB, Lane NE, Saxne T, Tyree B, Kraus VB Osteoarthritis Biomarkers Network. Classification of osteoarthritis biomarkers: a proposed approach. Osteoarthritis Cartilage. 2006 14 : 723 7.
185. Weidenbecher M, Henderson JH, Tucker HM, Baskin JZ, Awadallah A, Dennis JE. Hyaluronan-based scaffolds to tissue-engineer cartilage implants for laryngotracheal reconstruction. Laryngoscope. 2007 117 : 1745 9.
186. Weidenbecher M, Tucker HM, Awadallah A, Dennis JE. Fabrication of a neotrachea using engineered cartilage. Laryngoscope. 2008 118 : 593 8.